Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2007

Aug 23, 2007

34519_dirs_2007-08-23_31831553-b20b-4fa6-aafb-364b21f4a57b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2007-08-21

Reporting Person: ROTHSCHILD JONATHAN E (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2007-08-21 Common Stock, par value $0.10 per share P 1000 $3.68 Acquired 405223 Direct
2007-08-21 Common Stock, par value $0.10 per share P 1000 $3.74 Acquired 406223 Direct
2007-08-21 Common Stock, par value $0.10 per share P 200 $3.73 Acquired 406423 Direct
2007-08-21 Common Stock, par value $0.10 per share P 300 $3.68 Acquired 406723 Direct
2007-08-21 Common Stock, par value $0.10 per share P 300 $3.66 Acquired 407023 Direct
2007-08-21 Common Stock, par value $0.10 per share P 200 $3.69 Acquired 407223 Direct

Footnotes

F1: These shares of common stock were acquired by Arterio, Inc. a corporation owned solely by Mr. Rothschild.

F2: This figure includes 201,510 shares of common stock held by Arterio, Inc., a corporation owned solely by Mr. Rothschild.